By Jeff Overley ( April 2, 2013, 3:03 PM EDT) -- German drugmaker Merz Pharma Group on Tuesday launched a $383.5 million acquisition offer for California-based cosmetics company Obagi Medical Products Inc., topping a $344 million proposal from Valeant Pharmaceuticals International Inc. and potentially touching off a bidding war....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.